SEARCH

SEARCH BY CITATION

REFERENCES

  • Albagha OM, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, Cundy T, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Papapoulos S, Montes Jdel P, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di Stefano M, Ward LC, Walsh JP, Ralston SH (2011): Genetic Determinants of Paget's Disease (GDPD) Consortium. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet 43:685-689.
  • Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004): Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661-666.
  • Ashburner J (2007): A fast diffeomorphic image registration algorithm. Neuroimage 38:95-113.
  • Ashburner J, Friston KJ. (2000): Voxel-based morphometry—The methods. Neuroimage 11(6 Pt 1):805-821.
  • Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011): Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68:51-57.
  • Bates E, Wilson SM, Saygin AP, Dick F, Sereno MI, Knight RT, Dronkers NF (2003): Voxel-based lesion-symptom mapping. Nat Neurosci 6:448-450.
  • Batmanghelich N, Dalca A, Sabuncu MR, Golland P (2013): Joint modeling of imaging and genetics. Information Processing in Medical Imaging. Springer Berlin Heidelberg, Berlin, Germany pp 766-777.
  • Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA (2009): Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet 84:35-43.
  • Blank JB, Cawthon PM, Carrion-Petersen ML, Harper L, Johnson JP, Mitson E, Delay RR (2005): Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 26:557-568.
  • Blau CW, Cowley TR, O'Sullivan J, Grehan B, Browne TC, Kelly L, Birch A, Murphy N, Kelly AM, Kerskens CM, Lynch MA (2011): The age-related deficit in LTP is associated with changes in perfusion and blood-brain barrier permeability. Neurobiol Aging 33:1005.e231005.e35.
  • Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D (2007): Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol 64:1306-1311.
  • Caselli RJ, Dueck AC, Huentelman MJ, Lutz MW, Saunders AM, Reiman EM, Roses AD (2012): Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement 8:490-495.
  • Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995): Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773.
  • Filipovych R, Gaonkar B, Davatzikos C (2012): A Composite Multivariate Polygenic and Neuroimaging Score for Prediction of Conversion to Alzheimer's Disease. University College London, London, UK pp 105-108.
  • Folstein MF, Folstein SE, McHugh PR (1975): “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
  • Habas C, Kamdar N, Nguyen D, Prater K, Beckmann CF, Menon V, Greicius MD (2009): Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci 29:8586-8594.
  • Hayasaka S, Nichols TE (2004): Combining voxel intensity and cluster extent with permutation test framework. Neuroimage 23:54-63.
  • Hinman JD, Abraham CR (2007): What's behind the decline? The role of white matter in brain aging. Neurochem Res 32:2023-2031.
  • Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, Craig D, McGuinness B, Johnston J, Holmes C, Livingston G, Bass NJ, Gurling H, McQuillin A; GERAD Consortium; National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group, Holmans P, Jones L, Devlin B, Klei L, Barmada MM, Demirci FY, DeKosky ST, Lopez OL, Passmore P, Owen MJ, O'Donovan MC, Mayeux R, Kamboh MI, Williams J (2012): Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry 17:1316-1327.
  • Jun G, Vardarajan BN, Buros J, Yu CE, Hawk MV, Dombroski BA, Crane PK, Larson EB; Alzheimer's Disease Genetics Consortium, Mayeux R, Haines JL, Lunetta KL, Pericak-Vance MA, Schellenberg GD, Farrer LA (2012): Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol 69:1270-1279.
  • Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative, Sweet RA, Feingold E, DeKosky ST, Lopez OL (2012a): Genome-wide association analysis of age-at-onset in Alzheimer's disease. Mol Psychiatry 17:1340-1346.
  • Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative, Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM (2012b): Genome-wide association study of Alzheimer's disease. Transl Psychiatry 2:e117.
  • Kaup AR, Mirzakhanian H, Jeste DV, Eyler LT (2011): A review of the brain structure correlates of successful cognitive aging. J Neuropsychiatry Clin Neurosci 23:6-15.
  • Kimberg DY, Coslett HB, Schwartz MF (2007): Power in Voxel-based lesion-symptom mapping. J Cogn Neurosci 19:1067-1080.
  • Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998): Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453.
  • Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segrè AV, Speliotes EK, Wheeler E, Soranzo N, Park JH, Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon Smith A, Mägi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G, Winkler TW, Goddard ME, Sin Lo K, Palmer C, Workalemahu T, Aulchenko YS, Johansson A, Zillikens MC, Feitosa MF, Esko T, Johnson T, Ketkar S, Kraft P, Mangino M, Prokopenko I, Absher D, Albrecht E, Ernst F, Glazer NL, Hayward C, Hottenga JJ, Jacobs KB, Knowles JW, Kutalik Z, Monda KL, Polasek O, Preuss M, Rayner NW, Robertson NR, Steinthorsdottir V, Tyrer JP, Voight BF, Wiklund F, Xu J, Zhao JH, Nyholt DR, Pellikka N, Perola M, Perry JR, Surakka I, Tammesoo ML, Altmaier EL, Amin N, Aspelund T, Bhangale T, Boucher G, Chasman DI, Chen C, Coin L, Cooper MN, Dixon AL, Gibson Q, Grundberg E, Hao K, Juhani Junttila M, Kaplan LM, Kettunen J, König IR, Kwan T, Lawrence RW, Levinson DF, Lorentzon M, McKnight B, Morris AP, Müller M, Suh Ngwa J, Purcell S, Rafelt S, Salem RM, Salvi E, Sanna S, Shi J, Sovio U, Thompson JR, Turchin MC, Vandenput L, Verlaan DJ, Vitart V, White CC, Ziegler A, Almgren P, Balmforth AJ, Campbell H, Citterio L, De Grandi A, Dominiczak A, Duan J, Elliott P, Elosua R, Eriksson JG, Freimer NB, Geus EJ, Glorioso N, Haiqing S, Hartikainen AL, Havulinna AS, Hicks AA, Hui J, Igl W, Illig T, Jula A, Kajantie E, Kilpeläinen TO, Koiranen M, Kolcic I, Koskinen S, Kovacs P, Laitinen J, Liu J, Lokki ML, Marusic A, Maschio A, Meitinger T, Mulas A, Paré G, Parker AN, Peden JF, Petersmann A, Pichler I, Pietiläinen KH, Pouta A, Ridderstråle M, Rotter JI, Sambrook JG, Sanders AR, Schmidt CO, Sinisalo J, Smit JH, Stringham HM, Bragi Walters G, Widen E, Wild SH, Willemsen G, Zagato L, Zgaga L, Zitting P, Alavere H, Farrall M, McArdle WL, Nelis M, Peters MJ, Ripatti S, van Meurs JB, Aben KK, Ardlie KG, Beckmann JS, Beilby JP, Bergman RN, Bergmann S, Collins FS, Cusi D, den Heijer M, Eiriksdottir G, Gejman PV, Hall AS, Hamsten A, Huikuri HV, Iribarren C, Kähönen M, Kaprio J, Kathiresan S, Kiemeney L, Kocher T, Launer LJ, Lehtimäki T, Melander O, Mosley TH Jr, Musk AW, Nieminen MS, O'Donnell CJ, Ohlsson C, Oostra B, Palmer LJ, Raitakari O, Ridker PM, Rioux JD, Rissanen A, Rivolta C, Schunkert H, Shuldiner AR, Siscovick DS, Stumvoll M, Tönjes A, Tuomilehto J, van Ommen GJ, Viikari J, Heath AC, Martin NG, Montgomery GW, Province MA, Kayser M, Arnold AM, Atwood LD, Boerwinkle E, Chanock SJ, Deloukas P, Gieger C, Grönberg H, Hall P, Hattersley AT, Hengstenberg C, Hoffman W, Lathrop GM, Salomaa V, Schreiber S, Uda M, Waterworth D, Wright AF, Assimes TL, Barroso I, Hofman A, Mohlke KL, Boomsma DI, Caulfield MJ, Cupples LA, Erdmann J, Fox CS, Gudnason V, Gyllensten U, Harris TB, Hayes RB, Jarvelin MR, Mooser V, Munroe PB, Ouwehand WH, Penninx BW, Pramstaller PP, Quertermous T, Rudan I, Samani NJ, Spector TD, Völzke H, Watkins H, Wilson JF, Groop LC, Haritunians T, Hu FB, Kaplan RC, Metspalu A, North KE, Schlessinger D, Wareham NJ, Hunter DJ, O'Connell JR, Strachan DP, Wichmann HE, Borecki IB, van Duijn CM, Schadt EE, Thorsteinsdottir U, Peltonen L, Uitterlinden AG, Visscher PM, Chatterjee N, Loos RJ, Boehnke M, McCarthy MI, Ingelsson E, Lindgren CM, Abecasis GR, Stefansson K, Frayling TM, Hirschhorn JN (2010): Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467:832-838.
  • Lee Y-S, Silva AJ (2009): The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci 10:126-140.
  • Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, Griffith P, Obisesan TO, Shatz R, Borenstein A, Cupples LA, Lunetta KL, Fallin MD, Baldwin CT, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group (2011): A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol 68:1569-1579.
  • Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, Deyoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, van Amerongen M, van Dongen EP, Keijzers P, Kappen T, Borgdorff P, Bruins P, Derks EM, Kahn RS, Ophoff RA (2013): Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Mol Psychiatry 19:228234.
  • Magi R, Morris AP (2010): GWAMA: Software for genome-wide association meta-analysis. BMC Bioinform 11:288.
  • Magi R, Lindgren CM, Morris AP (2010): Meta-analysis of sex-specific genome-wide association studies. Genet Epidemiol 34:846-853.
  • Mauceri D, Freitag HE, Oliveira AMM, Bengtson CP, Bading H (2011): Nuclear calcium-VEGFD signaling controls maintenance of dendrite arborization necessary for memory formation. Neuron 71:117-130.
  • McClay JL, Adkins DE, Aberg K, Bukszar J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ (2011): Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. Neuropsychopharmacology 36:616-626.
  • Meng W, Butterworth J, Bradley DT, Hughes AE, Soler V, Calvas P, Malecaze F (2012): A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population. Invest Ophthalmol Vis Sci 53:7983-7988.
  • Montembeault M, Joubert S, Doyon J, Carrier J, Gagnon JF, Monchi O, Lungu O, Belleville S, Brambati SM (2012): The impact of aging on gray matter structural covariance networks. Neuroimage 63:754-759.
  • Morris JC (1993): The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43:2412-2414.
  • Neuhaus J (1999): Bias and efficiency loss due to misclassified responses in binary regression. Biometrika 86:843-855.
  • Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K (2005): Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—A large observational study of the determinants of fracture in older men. Contemp Clin Trials 26:569-585.
  • Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V (2010): Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21:691-724.
  • Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, Dehghan A, Deloukas P, Doney AS, Elliott P, Freimer N, Gateva V, Herder C, Hofman A, Hughes TE, Hunt S, Illig T, Inouye M, Isomaa B, Johnson T, Kong A, Krestyaninova M, Kuusisto J, Laakso M, Lim N, Lindblad U, Lindgren CM, McCann OT, Mohlke KL, Morris AD, Naitza S, Orrù M, Palmer CN, Pouta A, Randall J, Rathmann W, Saramies J, Scheet P, Scott LJ, Scuteri A, Sharp S, Sijbrands E, Smit JH, Song K, Steinthorsdottir V, Stringham HM, Tuomi T, Tuomilehto J, Uitterlinden AG, Voight BF, Waterworth D, Wichmann HE, Willemsen G, Witteman JC, Yuan X, Zhao JH, Zeggini E, Schlessinger D, Sandhu M, Boomsma DI, Uda M, Spector TD, Penninx BW, Altshuler D, Vollenweider P, Jarvelin MR, Lakatta E, Waeber G, Fox CS, Peltonen L, Groop LC, Mooser V, Cupples LA, Thorsteinsdottir U, Boehnke M, Barroso I, Van Duijn C, Dupuis J, Watanabe RM, Stefansson K, McCarthy MI, Wareham NJ, Meigs JB, Abecasis GR (2009): Variants in MTNR1B influence fasting glucose levels. Nat Genet 41:77-81.
  • Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007): PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
  • Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, Weiner MW, Saykin AJ (2013): APOE and BCHE as modulators of cerebral amyloid deposition: A florbetapir PET genome-wide association study. Mol Psychiatry. Available at: http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201319a.html.
  • Rankin KP, Kramer JH, Miller BL (2005): Patterns of cognitive and emotional empathy in frontotemporal lobar degeneration. Cogn Behav Neurol 18:28-36.
  • Raz N, Rodrigue KM (2006): Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev 30:730-748.
  • Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J, Jones CG, Zaitlen NA, Varilo T, Kaakinen M, Sovio U, Ruokonen A, Laitinen J, Jakkula E, Coin L, Hoggart C, Collins A, Turunen H, Gabriel S, Elliot P, McCarthy MI, Daly MJ, Järvelin MR, Freimer NB, Peltonen L (2009): Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41:35-46.
  • Sabuncu MR, Buckner RL, Smoller JW, Lee PH, Fischl B, Sperling RA (2012): The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cereb Cortex 22:2653-2661.
  • Seripa D, Bizzarro A, Pilotto A, Palmieri O, Panza F, D'Onofrio G, Gravina C, Archetti S, Daniele A, Borroni B, Padovani A, Masullo C (2012): TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia. J Alzheimers Dis 31:731-740.
  • Silver M, Janousova E, Hua X, Thompson PM, Montana G (2012): Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression. Neuroimage 63:1681-1694.
  • Sturm VE, Yokoyama JS, Seeley WW, Kramer JH, Miller BL, Rankin KP (2013): Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration. Proc Natl Acad Sci USA 110:9944-9949.
  • Sweet RA, Seltman H, Emanuel JE, Lopez OL, Becker JT, Bis JC, Weamer EA, DeMichele-Sweet MA, Kuller LH (2012): Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. Am J Psychiatry 169:954-962.
  • Teng EL, Chui HC (1987): The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48:314-318.
  • Thompson PM, Martin NG, Wright MJ (2010): Imaging genomics. Curr Opin Neurol 23:368-373.
  • Tomasi D, Volkow ND (2012): Aging and functional brain networks. Mol Psychiatry 17:471, 549-558.
  • Treinin M (2008): RIC-3 and nicotinic acetylcholine receptors: Biogenesis, properties, and diversity. Biotechnol J 3:1539-1547.
  • Vogt MT, Rubin DA, Palermo L, Christianson L, Kang JD, Nevitt MC, Cauley JA (2003): Lumbar spine listhesis in older African American women. Spine J 3:255-261.
  • Vounou M, Janousova E, Wolz R, Stein JL, Thompson PM, Rueckert D, Montana G (2012): Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease. Neuroimage 60:700-716.
  • Wang HY, Lee DH, Davis CB, Shank RP (2000): Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75:1155-1161.
  • Willer CJ, Li Y, Abecasis GR (2010): METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26:2190-2191.
  • Wilson SM, Brambati SM, Henry RG, Handwerker DA, Agosta F, Miller BL, Wilkins DP, Ogar JM, Gorno-Tempini ML (2009): The neural basis of surface dyslexia in semantic dementia. Brain 132(Pt 1):71-86.
  • Yaffe K (2007a): Metabolic syndrome and cognitive decline. Curr Alzheimer Res 4:123-126.
  • Yaffe K (2007b): Metabolic syndrome and cognitive disorders: Is the sum greater than its parts? Alzheimer Dis Assoc Disord 21:167-171.